Abstract |
Five human cancer cell lines (MKN 45, HT-29, WiDr, PAN-3-JCK, and CRL 1420) were used to evaluate the antitumor spectrum of UCN-01, which suppressed the growth of these digestive cancer cell lines. A human pancreatic cancer xenograft (CRL 1420) and breast cancer xenograft (MX-1) were used to determine their sensitivity to UCN-01, in nude mice. UCN-01 significantly suppressed the tumor growth of CRL 1420 at a dose of 10 mg/kg in a schedule of (qd x 5) x 2, but was ineffective for MX-1. While p21 protein expression was induced by UCN-01 in both CRL 1420 and MX-1, an accumulation of dephosphorylated ppRb was observed only in CRL 1420, resulting in G1 block as detected by flow cytometric analysis. The CDK 2 activity of MX-1 was almost 6 times higher than that of CRL 1420, which might account for the resistance of MX-1 to UCN-01 in spite of the induction of p21 in this strain. We conclude that the determinant of sensitivity to UCN-01 lies in the balance of CDK 2 kinase activity and p21 protein induction.
|
Authors | S Abe, T Kubota, Y Otani, T Furukawa, M Watanabe, K Kumai, M Kitajima |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 27
Issue 8
Pg. 1260-6
(Jul 2000)
ISSN: 0385-0684 [Print] Japan |
PMID | 10945025
(Publication Type: Journal Article)
|
Chemical References |
- Alkaloids
- 7-hydroxystaurosporine
- Protein Serine-Threonine Kinases
- CDC2-CDC28 Kinases
- Cdk2 protein, mouse
- Cyclin-Dependent Kinase 2
- Cyclin-Dependent Kinases
- Staurosporine
|
Topics |
- Alkaloids
(pharmacology)
- Animals
- CDC2-CDC28 Kinases
- Cell Cycle
(drug effects)
- Cell Division
(drug effects)
- Cyclin-Dependent Kinase 2
- Cyclin-Dependent Kinases
(metabolism)
- Drug Screening Assays, Antitumor
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Protein Serine-Threonine Kinases
(metabolism)
- Signal Transduction
- Staurosporine
(analogs & derivatives)
- Tumor Cells, Cultured
(drug effects)
|